Laregab 300mg Capsule contains Gabapentin, an anticonvulsant and neuropathic pain agent used primarily in the management of epilepsy and neuropathic pain disorders. Gabapentin acts by modulating the activity of voltage-gated calcium channels in the central nervous system, thereby reducing neuronal excitability and abnormal firing that contribute to seizure activity and neuropathic pain. Laregab is indicated as adjunctive therapy for partial seizures with or without secondary generalization in adults and pediatric patients aged 3 years and older. Additionally, it is prescribed for the treatment of postherpetic neuralgia and other neuropathic pain conditions. The recommended dosage varies depending on the indication, patient age, and renal function, with gradual titration advised to minimize adverse effects. Common side effects include dizziness, somnolence, peripheral edema, and fatigue, which are generally mild to moderate in intensity. Caution is warranted in patients with renal impairment, and dose adjustments may be necessary. Laregab should be used under medical supervision, with careful monitoring for efficacy and tolerability. Abrupt discontinuation is discouraged due to the risk of withdrawal seizures. This medication should be stored at controlled room temperature, away from moisture and direct light.